Acupuncture Policy
Customize your policy alerts
Sign up for mediviewcurative Policy MM-PNP-007 alerts
Get alerted when Policy MM-PNP-007 changes without checking for updates manually.
Monitor payer policy activity
Defines medical necessity, exclusions, and preauthorization considerations for acupuncture services provided to members managed by the Medical Utilization Management department.
No material clinical or coverage changes in this revision.
Coverage Criteria for Acupuncture
Medically Necessary Indications
Covered when ANY of the following indications are present:
Medically necessary indications
- Chronic neck pain: Chronic (minimum 12 weeks duration) neck pain>= 12 weeks
- Chronic headache: Chronic (minimum 12 weeks duration) headache>= 12 weeks
- Low back pain
- Nausea of pregnancy
- Osteoarthritis knee or hip (adjunctive): Pain from osteoarthritis of the knee or hip (adjunctive therapy)
- Post-operative/chemotherapy nausea and vomiting: Post-operative and chemotherapy-induced nausea and vomiting
- Post-operative dental pain
- Temporomandibular disorders (TMD)
Continuation / Maintenance
Continued treatment covered only if benefit demonstrated:
The following procedures, indications, and techniques are considered experimental or investigational and are not covered because effectiveness has not been established. This list is not all-inclusive but includes: abdominal obesity; acne; Alzheimer’s disease; asthma; autism spectrum disorders; Bell’s palsy; breast cancer–related hot flashes and lymphedema; cancer-induced bone pain; chemotherapy-induced leukopenia and neuropathic pain; fibromyalgia; gastric and peptic ulcer; Guillain-Barré–type conditions; neuropathic pain syndromes (e.g., post-herpetic neuralgia, painful neuropathies, diabetic peripheral neuropathy); Parkinson’s disease and related fatigue; phantom limb pain; plantar fasciitis; post-stroke shoulder pain; post-traumatic stress disorder; psychiatric disorders (e.g., anxiety, depression, schizophrenia); respiratory disorders; rheumatoid arthritis; tinnitus; urinary incontinence; whiplash; and many other conditions listed in the clinical document.
Maintenance acupuncture — defined as ongoing treatment when the member’s symptoms are neither regressing nor improving — is considered not medically necessary. If no clinical benefit is appreciated after 4 weeks of acupuncture, the treatment plan must be reevaluated and further sessions should not continue unless the member demonstrates meaningful improvement in symptoms.
Key Coding & Thresholds
Provider Actions, Prior Authorization & Documentation
Medical UM prior authorization oversight
The Medical Utilization Management (Medical UM) department governs prior authorization and coverage determinations for acupuncture under this policy. Acupuncture is considered medically necessary only for the specified indications in the policy; maintenance treatment without demonstrated benefit is not covered and prior authorization is managed by Medical UM.
Re-evaluation after 4-week trial
If no clinical benefit is appreciated after a four-week trial of acupuncture, the treatment plan must be reevaluated before continuing therapy.
Document clinical response to continue therapy
Documentation must demonstrate meaningful clinical improvement in symptoms when acupuncture is continued beyond the initial trial; lack of documented benefit after four weeks should trigger reevaluation and is required to justify further sessions.
Denial risk for maintenance / no improvement
Maintenance acupuncture where the member's symptoms are neither regressing nor improving is considered not medically necessary and may be denied if further treatment is provided without demonstrated benefit.
- Further acupuncture is not considered medically necessary if the member does not demonstrate meaningful improvement in symptoms.
Denial risk for experimental / investigational services
Procedures and indications explicitly listed as experimental and investigational in the policy (including acupuncture point injection/acupoint injection/biopuncture, use of the TDP lamp, dry needling, and the extensive list of conditions in the Experimental and Investigational section) are not supported and may be denied.
- Acupuncture point injection (acupoint injection/biopuncture) for listed conditions is considered experimental/investigational.
- Use of the Teding Dianci Pu (TDP) lamp as an adjunct to acupuncture is considered experimental/investigational.
- Dry needling is considered experimental/investigational.
- An extensive list of conditions (see policy) are listed as experimental/investigational and may be denied.
Background
Acupuncture in this policy includes both manual acupuncture and electroacupuncture. Coverage is distinguished by indication: certain pain- and nausea-related conditions are listed as medically necessary when criteria (including specified chronicity for some indications) are met, while a broad set of other conditions and specific techniques are identified as experimental or investigational and are not supported.
Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.